Coeptis Therapeutics Files FDA 513(g) Submission for CD38 In Vitro Companion Diagnostic

News provided by. Coeptis Therapeutics … 513(g) request will help initiate dialogue with FDA and guide regulatory pathway. WEXFORD, Pa., Aug.